Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BMS-986278 (admilparant) | 2170126-74-4 | 99.9% | C22H31N5O5 | 10MG
SDP

Catalog No. 5000260108
Encompass_Preferred

Admilparant is a potent, orally active lysophosphatidic acid receptor 1 (LPA1) antagonist used in preclinical research, notably for studies of pulmonary fibrotic diseases. It has been characterized for potency, formulation, and storage to support both in vitro and in vivo experiments.

  • Potent LPA1 antagonist with low-nanomolar activity (human Kb ≈ 6.9 nM, mouse ≈ 4.0 nM).
  • Suitable for in vitro and in vivo studies, with validated formulation options for dosing.
  • High purity supporting reproducible experimental results (reported ≈99.9% by batch HPLC).
  • Soluble in DMSO at high concentration for stock preparation (100 mg/mL).
  • Stable as a powdered solid under frozen storage for long-term use.

Catalog No. 50-002-60108 Supplier Medchemexpress LLC Supplier No. HY13985310MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Admilparant is a potent, orally active lysophosphatidic acid receptor 1 (LPA1) antagonist used in preclinical research, notably for studies of pulmonary fibrotic diseases. It has been characterized for potency, formulation, and storage to support both in vitro and in vivo experiments.

  • Potent LPA1 antagonist with low-nanomolar activity (human Kb ≈ 6.9 nM, mouse ≈ 4.0 nM).
  • Suitable for in vitro and in vivo studies, with validated formulation options for dosing.
  • High purity supporting reproducible experimental results (reported ≈99.9% by batch HPLC).
  • Soluble in DMSO at high concentration for stock preparation (100 mg/mL).
  • Stable as a powdered solid under frozen storage for long-term use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.